Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod
Healthcare Stocks Are Closing the Gap. Here Are the Latest Winners.
J&J, Stryker Among Potential Suitors for Nevro: Wolfe
Johnson & Johnson Announces Groundbreaking Nipocalimab Study Of Pregnant Individuals At High Risk For Early Onset Severe Hemolytic Disease Of The Fetus And Newborn Published In The New England Journal Of Medicine
Express News | J&J - Labeling Update for Linx Reflux Management System Will Provide More Patients Relief From Gastroesophageal Reflux Disease
Express News | Johnson & Johnson Medtech Announces Labeling Amendment of Linx™ Reflux Management System in U.S. to Include Patients With Barrett's Esophagus Experiencing Gastroesophageal Reflux Disease
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
Johnson & Johnson's (NYSE:JNJ) Investors Will Be Pleased With Their Favorable 37% Return Over the Last Five Years
Groundbreaking Nipocalimab Study of Pregnant Individuals at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn Published in The New England Journal of Medicine
Benadryl Parent's Stock Soars as Allergy Season Got a Lot Worse, Boosting Sales
Bayer (BAYRY) Q2 Earnings In Line, Nubeqa, Kerendia Boost Sales
Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
Kenvue's Stock Soars After Band-Aid, Tylenol Parent's Profit Surprisingly Rose
Express News | Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Johnson & Johnson Analyst Ratings
Kenvue Likely to Report Weaker Q2 Amid Ongoing Challenges, RBC Says
Looking At Johnson & Johnson's Recent Unusual Options Activity
Express News | J&J - Depuy Synthes Launches Its First Active Spine Robotics and Navigation Platform
DePuy Synthes Launches Its First Active Spine Robotics and Navigation Platform
The Bank of Japan's hawkish stance and escalating economic recession concerns resulted in the Japanese stock market falling for the second consecutive day.
Due to market expectations that Japan's central bank will further tighten monetary policy, the Japanese stock market has plummeted for the second consecutive day.